What happens when chronic migraine patients quit onabotulinumtoxina?

dc.contributor.authorDikmen, Pinar Yalinay
dc.contributor.authorKosak, Seda
dc.contributor.authorAydinlar, Elif Ilgaz
dc.contributor.authorKocaman, Ayse Sagduyu
dc.date.accessioned2025-10-16T15:26:57Z
dc.date.issued2017
dc.description.abstract18th International Headache Congress (IHC) of the International-Headache-Society, Vancouver, CANADA, SEP 07-10, 2017
dc.identifier.otherWOS:000410068300122
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/8461
dc.publisherSAGE PUBLICATIONS LTD
dc.sourceCEPHALALGIA
dc.titleWhat happens when chronic migraine patients quit onabotulinumtoxina?
dc.typeMeeting Abstract

Dosyalar

Koleksiyonlar